Electromed director exercises 40k options, sells 40k shares

Electromed, Inc. director Kathleen Skarvan reported a combination of option exercises and share sales.

Rhea-AI Filing Summary

Electromed, Inc. director Kathleen Skarvan reported a combination of option exercises and share sales. On May 15, 2026, she exercised employee stock options for 40,000 shares of common stock at an exercise price of $3.82 per share.

The filing also shows four open-market sales totaling 40,000 shares of common stock on the same date, at weighted average prices of $37.33, $36.258, $35.2422, and $34.3626 per share, each executed in multiple transactions within stated price ranges. The options exercised were fully vested and related derivative positions were exhausted.

Insider Trade Summary

Exercise and Sale: 40,000 shares ($1.27M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider SKARVAN KATHLEEN

Role Director

Sold 40,000 shs ($1.42M)

Approx. gross sale proceeds $1.42M

Approx. exercise cost $153K

Approx. pre-tax spread $1.27M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	40,000	$0.00	$0.00
Exercise	Common Stock	40,000	$3.82	$153K
Sale	Common Stock	8,150	$34.3626	$280K
Sale	Common Stock	19,032	$35.2422	$671K
Sale	Common Stock	9,256	$36.258	$336K
Sale	Common Stock	3,562	$37.33	$133K

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 35,622 shares (Direct)

Footnotes (4)

1. F1. Fully vested.
2. F2. Reflects the weighted average price of 8,150 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $33.86 to $34.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3. F3. Reflects the weighted average price of 19,032 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $34.872 to $35.86 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. F4. Reflects the weighted average price of 9,256 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $35.87 to $36.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 40,000 shares Option shares exercised: 40,000 shares Option exercise price: $3.82 per share +5 more

8 metrics

Shares sold 40,000 shares Total open-market common stock sales on May 15, 2026

Option shares exercised 40,000 shares Employee stock options converted to common stock

Option exercise price $3.82 per share Employee Stock Option (right to buy) exercise price

Sale price block 1 $37.33 per share Weighted average price for 3,562-share sale block

Sale price block 2 $36.258 per share Weighted average price for 9,256-share sale block

Sale price block 3 $35.2422 per share Weighted average price for 19,032-share sale block

Sale price block 4 $34.3626 per share Weighted average price for 8,150-share sale block

Option expiration July 1, 2026 Original expiration date of exercised options

Key Terms

open-market sale, Employee Stock Option (right to buy), derivative exercise/conversion, weighted average price, +1 more

5 terms

open-market sale financial

"transaction_action is described as "open-market sale" for the common stock transactions"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Employee Stock Option (right to buy) financial

"security_title lists "Employee Stock Option (right to buy)" as the derivative security"

derivative exercise/conversion financial

"transaction_action for the option is noted as "derivative exercise/conversion""

weighted average price financial

"footnotes state "Reflects the weighted average price" for each sale block"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

fully vested financial

"a footnote specifies the employee stock option as "Fully vested.""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Electromed (ELMD) director Kathleen Skarvan report?

Kathleen Skarvan reported exercising employee stock options for 40,000 shares of Electromed common stock and selling 40,000 shares in open-market transactions on May 15, 2026. The activity combined a derivative exercise with same-day share sales.

How many Electromed (ELMD) shares did Kathleen Skarvan sell on May 15, 2026?

She sold a total of 40,000 shares of Electromed common stock on May 15, 2026. The sales were split across four transactions of 3,562, 9,256, 19,032, and 8,150 shares at different weighted average prices.

At what prices did Kathleen Skarvan sell Electromed (ELMD) shares?

Her reported sales used weighted average prices of $37.33, $36.258, $35.2422, and $34.3626 per share. Each figure reflects multiple trades within specified price ranges disclosed in the footnotes for that sale block.

What were the terms of Kathleen Skarvan’s Electromed stock option exercise?

She exercised 40,000 employee stock options for Electromed common stock at an exercise price of $3.82 per share. The filing notes these options were fully vested and carried an expiration date of July 1, 2026 before exercise.

Does the Electromed (ELMD) Form 4 show remaining stock options for Kathleen Skarvan?

The filing indicates 40,000 options were exercised and that the related derivative position now shows 0 derivative securities remaining. This suggests the reported employee stock option grant was fully exercised in the disclosed transaction.

Were Kathleen Skarvan’s Electromed (ELMD) share sales open-market transactions?

Yes. Each share sale is coded as an S transaction and described as an open-market or private transaction. The reported trades on May 15, 2026 used weighted average prices across multiple executions within defined price ranges.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SKARVAN KATHLEEN

(Last) (First) (Middle)

500 SIXTH AVENUE NW

(Street)

NEW PRAGUE MINNESOTA 56071

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		M		40,000	A	$3.82	75,622	D
Common Stock	05/15/2026		S		8,150	D	$34.3626(2)	67,472	D
Common Stock	05/15/2026		S		19,032	D	$35.2422(3)	48,440	D
Common Stock	05/15/2026		S		9,256	D	$36.258(4)	39,184	D
Common Stock	05/15/2026		S		3,562	D	$37.33	35,622	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$3.82	05/15/2026		M			40,000	(1)	07/01/2026	Common Stock	40,000	$0	0	D

Explanation of Responses:

1. Fully vested.

2. Reflects the weighted average price of 8,150 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $33.86 to $34.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. Reflects the weighted average price of 19,032 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $34.872 to $35.86 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Reflects the weighted average price of 9,256 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $35.87 to $36.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Joshua L. Colburn, attorney-in-fact for Kathleen S. Skarvan	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)